Intended for healthcare professionals

Letters Drugs for opioid dependence

Neonatal abstinence syndrome can be a problem

BMJ 2012; 344 doi: (Published 19 June 2012) Cite this as: BMJ 2012;344:e4200
  1. Helen Mactier, consultant neonatologist1,
  2. Laura McGlone, neonatal paediatric grid trainee1,
  3. Ruth Hamilton, consultant clinical scientist2,
  4. Jane R MacKinnon, consultant paediatric ophthalmologist3
  1. 1Princess Royal Maternity, Glasgow G31 2ER, UK
  2. 2Department of Clinical Physics and Bioengineering, University of Glasgow and the Royal Hospital for Sick Children, Glasgow, UK
  3. 3Royal Hospital for Sick Children, Glasgow, UK
  1. helen.mactier{at}

Farrell and colleagues note that in pregnancy “methadone (substitution treatment) is safe and effective in terms of consistently better obstetric and perinatal outcomes.”1 They indicate that the only complication for the baby is a risk of neonatal abstinence syndrome and suggest that this “can be readily managed with withdrawal management and …

View Full Text

Log in

Log in through your institution


* For online subscription